Capital Flow Monitor · Sponsors · CIK 2073993
Antigenix Therapeutics, Inc.
300 CARNEGIE CENTER, SUITE 150, PRINCETON, NJ, 08540 · (317) 552-5240
Other Health Care · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$8.4M
Sold
$3.4M
% sold
40.2%
Investors
17
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-24 | D ·current | 506(b) | $8.4M | $3.4M | 40.2% | 17 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Christopher Whitfield — Executive Officer / Director, New Jersey, NJ
-
Shaun Hawkins — Director, New Jersey, NJ
2 other raises
- ZeroCarb Inc. $213K of $213K · 100.0%
- GeniPhys, Inc. $3.0M of $5.6M · 54.1%
-
Kwesi Frimpong-Boateng — Director, New Jersey, NJ
1 other raise
- T.Rx Capital Fund I, LP $77.2M of $175.0M · 44.1%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.